These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 20019836)

  • 1. Peptides derived from type IV collagen, CXC chemokines, and thrombospondin-1 domain-containing proteins inhibit neovascularization and suppress tumor growth in MDA-MB-231 breast cancer xenografts.
    Koskimaki JE; Karagiannis ED; Rosca EV; Vesuna F; Winnard PT; Raman V; Bhujwalla ZM; Popel AS
    Neoplasia; 2009 Dec; 11(12):1285-91. PubMed ID: 20019836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Collagen IV and CXC chemokine-derived antiangiogenic peptides suppress glioma xenograft growth.
    Rosca EV; Lal B; Koskimaki JE; Popel AS; Laterra J
    Anticancer Drugs; 2012 Aug; 23(7):706-12. PubMed ID: 22495619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pentastatin-1, a collagen IV derived 20-mer peptide, suppresses tumor growth in a small cell lung cancer xenograft model.
    Koskimaki JE; Karagiannis ED; Tang BC; Hammers H; Watkins DN; Pili R; Popel AS
    BMC Cancer; 2010 Feb; 10():29. PubMed ID: 20122172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a biomimetic peptide derived from collagen IV with anti-angiogenic activity in breast cancer.
    Rosca EV; Koskimaki JE; Pandey NB; Wolff AC; Popel AS
    Cancer Biol Ther; 2011 Nov; 12(9):808-17. PubMed ID: 21878750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of breast cancer growth and metastasis by a biomimetic peptide.
    Lee E; Lee SJ; Koskimaki JE; Han Z; Pandey NB; Popel AS
    Sci Rep; 2014 Nov; 4():7139. PubMed ID: 25409905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD36-mediated activation of endothelial cell apoptosis by an N-terminal recombinant fragment of thrombospondin-2 inhibits breast cancer growth and metastasis in vivo.
    Koch M; Hussein F; Woeste A; Gründker C; Frontzek K; Emons G; Hawighorst T
    Breast Cancer Res Treat; 2011 Jul; 128(2):337-46. PubMed ID: 20714802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nef-M1, a peptide antagonist of CXCR4, inhibits tumor angiogenesis and epithelial‑to‑mesenchymal transition in colon and breast cancers.
    Katkoori VR; Basson MD; Bond VC; Manne U; Bumpers HL
    Oncotarget; 2015 Sep; 6(29):27763-77. PubMed ID: 26318034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells.
    Zhang GM; Zhang YM; Fu SB; Liu XH; Fu X; Yu Y; Zhang ZY
    Chin Med J (Engl); 2008 Nov; 121(22):2324-30. PubMed ID: 19080341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Norcantharidin: a potential antiangiogenic agent for gallbladder cancers in vitro and in vivo.
    Zhang JT; Fan YZ; Chen CQ; Zhao ZM; Sun W
    Int J Oncol; 2012 May; 40(5):1501-14. PubMed ID: 22200632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suberoylanilide hydroxamic acid (Zolinza/vorinostat) sensitizes TRAIL-resistant breast cancer cells orthotopically implanted in BALB/c nude mice.
    Shankar S; Davis R; Singh KP; Kurzrock R; Ross DD; Srivastava RK
    Mol Cancer Ther; 2009 Jun; 8(6):1596-605. PubMed ID: 19509267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.
    Huang SW; Lien JC; Kuo SC; Huang TF
    Carcinogenesis; 2012 May; 33(5):1022-30. PubMed ID: 22436611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of metastasis, angiogenesis, and tumor growth by Chinese herbal cocktail Tien-Hsien Liquid.
    Chia JS; Du JL; Hsu WB; Sun A; Chiang CP; Wang WB
    BMC Cancer; 2010 Apr; 10():175. PubMed ID: 20429953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Inhibitation of tumor angiogenesis, growth and metastasis by blocking VEGF paracrine pathway].
    Wang F; Tian YH; Li L; Chen XF; Hu HH; Li CY; Huang Q
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2002 Mar; 34(2):165-70. PubMed ID: 12006990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiangiogenic and antitumor activities of peptide inhibiting the vascular endothelial growth factor binding to neuropilin-1.
    Starzec A; Vassy R; Martin A; Lecouvey M; Di Benedetto M; Crépin M; Perret GY
    Life Sci; 2006 Nov; 79(25):2370-81. PubMed ID: 16959272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen receptor beta inhibits angiogenesis and growth of T47D breast cancer xenografts.
    Hartman J; Lindberg K; Morani A; Inzunza J; Ström A; Gustafsson JA
    Cancer Res; 2006 Dec; 66(23):11207-13. PubMed ID: 17145865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptides derived from type I thrombospondin repeat-containing proteins of the CCN family inhibit proliferation and migration of endothelial cells.
    Karagiannis ED; Popel AS
    Int J Biochem Cell Biol; 2007; 39(12):2314-23. PubMed ID: 17707681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual-function synthetic peptide derived from BMP4 for highly efficient tumor targeting and antiangiogenesis.
    Choi SH; Lee JY; Suh JS; Park YS; Chung CP; Park YJ
    Int J Nanomedicine; 2016; 11():4643-4656. PubMed ID: 27695323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual function of RGD-modified VEGI-192 for breast cancer treatment.
    Wu J; Jiang Y; Yang W; He Z; Meng S; Zhang Q; Lin M; Zhang H; Li W; Yang Y; Jia Y; Qian L; Lu D; Cai W; Luo G; Wang Y; Zhu X; Li M
    Bioconjug Chem; 2012 Apr; 23(4):796-804. PubMed ID: 22455451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of host microenvironment in angiogenesis and microvascular functions in human breast cancer xenografts: mammary fat pad versus cranial tumors.
    Monsky WL; Mouta Carreira C; Tsuzuki Y; Gohongi T; Fukumura D; Jain RK
    Clin Cancer Res; 2002 Apr; 8(4):1008-13. PubMed ID: 11948107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of vascular endothelial growth factor reduces angiogenesis and modulates immune cell infiltration of orthotopic breast cancer xenografts.
    Roland CL; Dineen SP; Lynn KD; Sullivan LA; Dellinger MT; Sadegh L; Sullivan JP; Shames DS; Brekken RA
    Mol Cancer Ther; 2009 Jul; 8(7):1761-71. PubMed ID: 19567820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.